Frontlight ResearchEarly access
TerminatedNo phase
Open-Label Prospective Study Comparing Long-Term Outcome With or Without HFNC in Patients With Stable Hypercapnic COPD
Key facts
- Who runs it
- Turku University Hospital
- Where
- Finland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 3 people enrolled
- Started
- 21 Apr 2022
- Ended
- 30 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- HFNC Airvo
- Standard care
- Record updated
- 29 December 2025
- Why it stopped
- It was not possible to achieve recruitment target
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aims of the study are to compare long-term one-year outcome with or without AirvoTM in stabile hypercapnic COPD patients, who are non-compliant to NIV after an acute exacerbation of COPD.
The 2 groups in the trial
- AirvoExisting treatment, for comparison
Patients allocated to use Airvo device
Treatment: HFNC Airvo
- ControlPlacebo, for comparison
Patients not using Airvo, standard care
Treatment: Standard care
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Open-Label Prospective Study Comparing Long-Term Outcome With or Without High-flow Nasal Cannula AirvoTM in Patients With Stable Hypercapnic COPD
- Record updated
- 29 December 2025